Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cancer Letters|October 5, 2010
Targeted therapies of cancer: angiogenesis inhibition seems not enoughIlse Roodink, William P J LeendersBMC Cancer|August 26, 2009
Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignanciesIlse Roodink, Kiek Verrijp, Jos Raats, et al.International Journal of Cancer|June 29, 2006
Development of the tumor vascular bed in response to hypoxia-induced VEGF-A differs from that in tumors with constitutive VEGF-A expressionIlse Roodink, Jeroen van der Laak, Benno Kusters, et al.The American Journal of Pathology|November 1, 2008
Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progressionIlse Roodink, Gürsah Kats, Léon van Kempen, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|October 14, 2009
Isolation of targeting nanobodies against co-opted tumor vasculatureIlse Roodink, Maarten Franssen, Malou Zuidscherwoude, et al.Cancer Research|September 17, 2005
Plexin D1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy?Ilse Roodink, Jos Raats, Bert van der Zwaag, et al.The Journal of Pathology|September 5, 2009
Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinomaGursah Kats-Ugurlu, Ilse Roodink, Mirjam de Weijert, et al.Biomacromolecules|January 21, 2026
Engineering Elastin-Like Peptide-Based Nanoparticles displaying Variable Domain of the Heavy Chain of Heavy-Chain-Only Antibodies for SARS-CoV-2 NeutralizationDuc H T Le, Jenny van Oostrum, Els van de Westerlo, et al.Oncotarget|October 1, 2016
In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150GluedSanne A M van Lith, Ilse Roodink, Joost J C Verhoeff, et al.Biomedicines|March 28, 2024
Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading VirusIlse Roodink, Maartje van Erp, Andra Li, et al.Pageof 1